Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Common Warts Market Size Changed, over the years?
The market size for common warts has seen robust growth in the past few years. It is projected to rise from $2.13 billion in 2024 to $2.26 billion in 2025, with a compound annual growth rate (CAGR) of 6.2%. The historical growth can be correlated with the heightened awareness of skin health, a surge in the prevalence of warts, an escalating demand for non-invasive procedures, an increased uptake of cryotherapy, and the expansion of dermatology clinics.
How Much Will the Common Warts Market Be Worth in 2029?
The market for common warts is projected to experience substantial growth in the near future, expected to surge to $2.83 billion in 2029, advancing at a compound annual growth rate (CAGR) of 5.8%. This anticipated growth during the forecast period is primarily due to reasons such as the growing elderly population, increasing instances of viral infections, higher uptake of progressive dermatological therapies, burgeoning demand for customized treatments, and a rising inclination towards homecare solutions among consumers. Key trends set to shape the market in the forecast timeframe encompass advancements in dermatological treatments, a burgeoning healthcare infrastructure, technological innovation in wart elimination therapies, improved awareness regarding treatment alternatives, and a transition towards minimally invasive treatments.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21154&type=smp
Which is the Largest Company in the Common Warts Market?
Major companies operating in the common warts market are Major players in the market are AbbVie Inc., GlaxoSmithKline plc, Sun Pharmaceutical Industries Limited, Perrigo Company plc, Holland & Barrett International Limited, Prestige Consumer Healthcare Inc., Maruho Co. Ltd., Novan Inc., X4 Pharmaceuticals Inc., Aclaris Therapeutics Inc., Verrica Pharmaceuticals Inc., RXi Pharmaceuticals Corporation, Scholl’s Wellness Company, Nielsen BioSciences Inc., Cassiopea S.p.A., Orgenesis Inc., KinoPharma Inc., Naturasil, Veradermics Inc., KinoPharma Co. Ltd.
What Are the Main Market Drivers in the Common Warts Industry?
The prevalence of viral infections is anticipated to boost the expansion of the common warts market. Viral infections denote diseases brought about by the invasion, propagation, and dissemination of viruses within the human body, which affects cells and the immune system. Factors like globalization, urbanization, climate change, deforestation, and impaired immune responses contribute to the rise of these infections. Targeted treatment for common warts focuses on the human papillomavirus (HPV), the virus that causes wart development, and brings critical relief to patients with viral infections by mitigating virus transmission, alleviating discomfort, and facilitating healing, thereby averting potential issues like secondary infections or scarring and enhancing the patient’s life quality. To exemplify, the Centers for Disease Control and Prevention, a legislated agency in the US, reported that between 2019 and 2024, PCR-confirmed varicella cases surged by 62% from 29% to 47%. Additionally, as per the data from the National Foundation for Infectious Diseases, another health-related organization in the US, it’s estimated that there are approximately 14 million new instances of HPV infection every year in the United States. Thus, the escalating prevalence of viral infections is fuelling the growth of the common warts market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=21154&type=smp
How Is the Common Warts Market Segments Structured?
The common warts market covered in this report is segmented –
1) By Treatment Method: Cryotherapy, Laser Treatment, Electrosurgery, Topical Medications
2) By Patient Demographics: Children, Adults, Elderly
3) By Disease Stage: Initial Stage, Moderate Stage, Severe Stage
4) By End User: Hospitals, Dermatology Clinics, Home Care
Subsegments:
1) By Cryotherapy: Liquid Nitrogen Therapy, Carbon Dioxide Therapy
2) By Laser Treatment: Pulsed-Dye Laser Therapy, Carbon Dioxide (CO2) Laser Therapy
3) By Electrosurgery: Curettage And Electrosurgical Removal, High-Frequency Electrosurgical Ablation
4) By Topical Medications: Salicylic Acid-Based Therapy, Immunotherapy-Based Topicals, Retinoid-Based Therapy
What Strategic Trends Are Transforming the Common Warts Market?
Leading firms in the common warts market are zeroing in on progressive cutting-edge treatments like dermatological therapies to answer to the escalating needs for effective and readily available solutions. These efforts are aimed at improving patient results and broadening their market footprint in the dermatology sector. Dermatological solutions are treatments targeting skin conditions that include infections, inflammations, and disorders. For example, in May 2024, a US-based company, Verrica Pharmaceuticals, struck a licensing deal with Torii Pharmaceutical Co. Ltd., which is located in Japan. The partnership is geared toward financing a global Phase 3 clinical trial for YCANTH, a common warts treatment. This deal propels the late-stage development of YCANTH, broadening its possible global impact. Torii Pharmaceuticals will provide the financial backing needed to drive the study forward. This allows both corporations to strengthen their dermatology offerings and boost their global market presence.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/common-warts-global-market-report
Which Global Regions Offer the Highest Growth in the Common Warts Market?
North America was the largest region in the common warts market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the common warts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21154
This Report Delivers Insight On:
1. How big is the common warts market, and how is it changing globally?
2. Who are the major companies in the common warts market, and how are they performing?
3. What are the key opportunities and risks in the common warts market right now?
4. Which products or customer segments are growing the most in the common warts market?
5. What factors are helping or slowing down the growth of the common warts market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model